Great Lakes Advisors, LLC Ultragenyx Pharmaceutical Inc. Transaction History
Great Lakes Advisors, LLC
- $10.8 Billion
- Q4 2024
A detailed history of Great Lakes Advisors, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Great Lakes Advisors, LLC holds 191,129 shares of RARE stock, worth $7.8 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
191,129
Previous 199,253
4.08%
Holding current value
$7.8 Million
Previous $11.1 Million
27.36%
% of portfolio
0.07%
Previous 0.1%
Shares
11 transactions
Others Institutions Holding RARE
# of Institutions
344Shares Held
86.6MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$409 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$229 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$175 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$111 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$103 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.86B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...